WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2003060158) APOE GENOTYPE AS A PROGNOSTIC MARKER FOR HEPATITIS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2003/060158    International Application No.:    PCT/GB2003/000104
Publication Date: 24.07.2003 International Filing Date: 13.01.2003
IPC:
C12Q 1/68 (2006.01), C12Q 1/70 (2006.01)
Applicants: THE UNIVERSITY OF MANCHESTER INSTITUTE OF SCIENCE AND TECHNOLOGY [GB/GB]; P.O. Box 88, Sackville Street, Manchester M13 9PL (GB) (For All Designated States Except US).
THE UNIVERSITY OF NOTTINGHAM [GB/GB]; University Park, Nottingham NG7 2RD (GB) (For All Designated States Except US).
ITZHAKI, Ruth [GB/GB]; (GB) (For US Only).
WOZNIAK, Matthew [GB/GB]; (GB) (For US Only).
IRVING, William [GB/GB]; (GB) (For US Only)
Inventors: ITZHAKI, Ruth; (GB).
WOZNIAK, Matthew; (GB).
IRVING, William; (GB)
Agent: BANFORD, Paul, Clifford; Marks & Clerk, 43 Park Place, Leeds LS1 2RYS (GB)
Priority Data:
0200757.3 15.01.2002 GB
Title (EN) APOE GENOTYPE AS A PROGNOSTIC MARKER FOR HEPATITIS
(FR) METHODE DE DIAGNOSTIC
Abstract: front page image
(EN)The invention relates to a method for determining whether or not a patient infected with hepatitis C is likely to develop severe liver disease. The method comprises determining the ApoE genotype of the patient, where a patient expressing the ApoE4 isoform is less likely to develop severe liver disease than a patient expressing only the ApoE2 or ApoE3 isoforms.
(FR)L'invention se rapporte à une méthode permettant de déterminer si un patient atteint par l'hépatite C est ou n'est pas susceptible de développer une maladie du foie grave. Cette méthode consiste à déterminer le génotype ApoE du patient : un patient exprimant l'isoforme ApoE4 est moins susceptible de développer une maladie du foie grave qu'un patient exprimant uniquement les isoformes ApoE2 ou ApoE3.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, OM, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)